Compare FSI & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FSI | NSPR |
|---|---|---|
| Founded | 1991 | 2005 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.0M | 77.5M |
| IPO Year | 2000 | 2009 |
| Metric | FSI | NSPR |
|---|---|---|
| Price | $5.56 | $1.78 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | 15.4K | ★ 34.4K |
| Earning Date | 03-31-2026 | 03-18-2026 |
| Dividend Yield | ★ 1.80% | N/A |
| EPS Growth | ★ 9.09 | N/A |
| EPS | ★ 0.09 | N/A |
| Revenue | ★ $15,494,325.00 | $2,310,000.00 |
| Revenue This Year | $4.11 | $22.91 |
| Revenue Next Year | $58.09 | $72.30 |
| P/E Ratio | $61.78 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.46 | $1.51 |
| 52 Week High | $11.48 | $2.94 |
| Indicator | FSI | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 47.32 | 61.81 |
| Support Level | $5.48 | $1.59 |
| Resistance Level | $6.08 | $2.51 |
| Average True Range (ATR) | 0.21 | 0.09 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 38.81 | 63.75 |
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.